most citedChemistry42: An AI-based platform for de novo molecular design

10 citations · 10 across the 5 of their papers we have counts for

collaborators

5 papers

cs.LG2026

Training Chemical Plausibility-Aware Large Language Models for Single-Step Retrosynthesis

Bogdan Zagribelnyy, Ivan Ilin, Nikita Bondarev +5

Single-step retrosynthesis is a central component of computer-aided synthesis planning, yet its intrinsically one-to-many nature is poorly captured by single-answer evaluation and…

cs.LG2026

URSA: Chemistry-Aware Benchmark for Utilitarian Retrosynthesis Assessment

Bogdan Zagribelnyy, Ivan Ilin, Nikita Bondarev +7

Synthesis planning aiming to find pathways of reactions for a target molecule is one of the most important and challenging tasks in drug discovery. Recent progress has produced bot…

cs.LG2026

MMAI Gym for Science: Training Liquid Foundation Models for Drug Discovery

Maksim Kuznetsov, Zulfat Miftahutdinov, Rim Shayakhmetov +17

General-purpose large language models (LLMs) that rely on in-context learning do not reliably deliver the scientific understanding and performance required for drug discovery tasks…

cs.LG2026

When Single Answer Is Not Enough: Rethinking Single-Step Retrosynthesis Benchmarks for LLMs

Bogdan Zagribelnyy, Ivan Ilin, Maksim Kuznetsov +10

Recent progress has expanded the use of large language models (LLMs) in drug discovery, including synthesis planning. However, objective evaluation of retrosynthesis performance re…

cs.AI2021★ 10 cited

Chemistry42: An AI-based platform for de novo molecular design

Yan A. Ivanenkov, Alex Zhebrak, Dmitry Bezrukov +7

Chemistry42 is a software platform for de novo small molecule design that integrates Artificial Intelligence (AI) techniques with computational and medicinal chemistry methods. Che…